AMT-562 in Patients With Selected Advanced Solid Tumors
NCT06199908
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
AMT-562
Sponsor
Multitude Therapeutics (Australia) Pty Ltd